Tag: treatment

Non-Pharmacological Treatment of Mild Cognitive Impairment and Dementia

Non-pharmacological treatments play a critical role in preventing and slowing the progression of Alzheimer’s disease and related dementias. This presentation will provide the latest updates on prevention and treatment strategies, emphasizing the importance of managing midlife risk factors and adopting evidence-based lifestyle interventions. Attendees will gain practical, actionable steps to support cognitive health and learn about a comprehensive range of local, state, regional, and national resources available for individuals and families living with memory loss and dementia.

Participants in this webinar will be able to:

  • List risk factors for cognitive impairment and dementia and ways to reduce these risks through improved management.
  • Identify lifestyle interventions that have an impact on cognition and neurological disease processes, from prodromal phases to early dementia.
  • Identify local, state, regional, and national programs and services to improve the quality of life for individuals and families living with dementia.

About the Presenter:
Kristoffer Rhoads, PhD, is a Professor of Neurology at the University of Washington School of Medicine and serves as the Director of the Division of Neuropsychology at Harborview Medical Center. He specializes in the evaluation and treatment of mild cognitive impairment and dementia. Dr. Rhoads currently serves as the Governor-appointed Chair of the Health and Medical Subcommittee for the Washington State Dementia Action Collaborative and is also the Director and Co-lead of UW Project ECHO Dementia

*This webinar is designed for professionals and family caregivers. Eligible professionals can claim ONE FREE CE credit within 60 days of the live webinar by attending the live event or watching the recorded program.

Developments in Alzheimer’s Research in Hawaiʻi: Trontinemab with Brainshuttle™ Technology

There are exciting developments in Alzheimer’s research in Hawaiʻi. In November 2025, Hawaiʻi Pacific Neuroscience announced the launch of a new clinical trial for the novel Alzheimer’s Trontinemab treatment engineered with Brainshuttle™ Technology. Early research results have shown low rates of bleeding in the brain or ARIA (Amyloid Related Imaging Abnormalities) and a faster clearing of Amyloid plaques in the brain. Hawaiʻi Pacific Neuroscience is currently accepting study participants in Hawaiʻi who are 50 years to 90 years old and experiencing early stage Alzheimer’s disease. Learn more at their website and watch Dr. Liow’s KHON2 TV News Interview.

For more information, check out the NIH Clinical Trial Information or contact the Hawaiʻi Pacific Neuroscience Memory Disorder Center & Alzheimer’s Research Unit and call (808) 564-6141 or email info@HawaiiNeuroscience.com

 

 

This is listed for informational purposes only. The government does not review or approve the safety and science of all studies listed on this website. Choosing to join a study is an important personal decision. Before you join a study, learn about the possible risks and benefits and discuss all options with your health care professional.

Follow Us on Social Media

Sign Up for Our Email Newsletter

Receive News, Alerts & Updates via Email

You are now leaving the Hawaii Dementia Initiative website to visit an external site.